Agra Hospital Successfully Implants Vanishing Stent In Businessman

A bioresorbable vascular scaffold (BVS) or "vanishing stent" was successfully implanted for the first time in a businessman for coronary artery disease (CAD) by doctors at a super-speciality hospital in Agra.

CAD develops when the arteries that supply blood to the heart become narrowed or blocked by a build-up of fatty deposits called plaque. As a result, it gets harder for the arteries to supply blood to the heart.

Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
Transdermal hormone replacement therapy (HRT) does not reduce the risk of cardiac events in postmenopausal women with existing coronary artery

The businessman N.C. Jain, 55, was implanted the "vanishing stent" Thursday.

"BVS or Absorb is the latest advance in CAD therapy. A non-metallic mesh tube is delivered on an angioplasty balloon to treat a narrowed artery, similar to a stent, but it slowly dissolves once the blocked artery can function naturally again and stay open on its own," senior cardiologist at the Lotus Super Speciality Hospital, Suvir Gupta told IANS.

Gupta said: "Similar to the way a cast supports a broken arm and is then removed, a BVS supports your vessel until it has the ability and strength to stay open on its own."

Insights into the Genetic Causes of Coronary Artery Disease and Heart Attacks: Researchers
Researchers report the identification of 15 genetic regions newly associated with the disease, bringing to 46 the number of regions associated with CAD risk.

"Gradually, over a period of two years, BVS breaks down into elements already found in your body -- water (H2O) and carbon dioxide (CO2) -- and gets naturally eliminated."

According to Gupta, this was the second implant in UP. The first one was done Dec 20 last year.

Coronary Artery Disease's New Savior May Be A Drug-Eluting Stent
A bioabsorbable, drug-eluting stent appears to be a safe and effective way of treating blocked coronary arteries, according to results from the open-label ABSORB study.

The potential long-term benefits of a scaffold that dissolves are significant, he said.

*The vessel may expand and contract to increase the flow of blood to the heart in response to normal activities such as exercising.

Racial Differences Depicted In Coronary Artery Disease CT
While obesity is considered a cardiovascular risk factor African-American patients with coronary artery disease (CAD) have much less fat around their hearts compared to Caucasian patients.

*The treatment and diagnostic options are broadened.

*The need for long-term treatment with anti-clotting medications may be reduced.

*Future interventions would be un-obstructed by a permanent implant.

Costing Rs.2.80 to 3 lakh, BVS has been tested in more than 3,000 patients in 30 countries, including India.

It is available for use in India now after necessary permission from the Drug Controller General of India.

More than 40,000 people in India every year get their arteries supplying blood to the heart unblocked through angioplasty.

Since the problem was becoming an epidemic now in India, particularly among men, due to faulty life-styles and food habits, the latest advance comes as a huge relief as earlier the metallic stents had patients dependent on drugs lifelong.

Source-IANS